1. Home
  2. ALLO vs BSVN Comparison

ALLO vs BSVN Comparison

Compare ALLO & BSVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$1.69

Market Cap

597.7M

Sector

Health Care

ML Signal

HOLD

Logo Bank7 Corp.

BSVN

Bank7 Corp.

HOLD

Current Price

$54.60

Market Cap

519.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLO
BSVN
Founded
2017
2004
Country
United States
United States
Employees
N/A
125
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
597.7M
519.7M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
ALLO
BSVN
Price
$1.69
$54.60
Analyst Decision
Strong Buy
Buy
Analyst Count
15
3
Target Price
$8.35
$53.67
AVG Volume (30 Days)
4.8M
41.9K
Earning Date
05-07-2026
04-14-2026
Dividend Yield
N/A
2.48%
EPS Growth
34.09
N/A
EPS
N/A
2.12
Revenue
N/A
N/A
Revenue This Year
N/A
$5.05
Revenue Next Year
$142,416.42
$4.05
P/E Ratio
N/A
$25.74
Revenue Growth
N/A
N/A
52 Week Low
$1.04
$38.50
52 Week High
$4.46
$57.77

Technical Indicators

Market Signals
Indicator
ALLO
BSVN
Relative Strength Index (RSI) 35.42 58.91
Support Level $1.59 $51.04
Resistance Level $1.92 $55.41
Average True Range (ATR) 0.08 1.63
MACD -0.03 -0.02
Stochastic Oscillator 6.58 54.12

Price Performance

Historical Comparison
ALLO
BSVN

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).

About BSVN Bank7 Corp.

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.

Share on Social Networks: